EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy

Sandra López-Cerdá iD, Giuseppina Molinaro, Rubén Pareja Tello iD, Alexandra Correia, Sarojinidevi Künig iD, Peter Steinberger iD, Michael Jeltsch, Jouni T Hirvonen iD, Goncalo Barreto, Johannes Stöckl, Hélder A Santos iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c02363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Sandra López-Cerdá und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Program, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Helsinki FI-00014, Finland. Hauptthemen laut MEDLINE: Tendinopathy, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Universitair Medisch Centrum Groningen, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TendinopathyNanoparticlesAnimalsHumansMicePolymersRNA, Small InterferingBudesonideMacrophagesInflammationLipidsFibrosis

Stichwörter der Autor:innen

dual drug deliverylipid−polymer hybrid nanoparticlesmacrophagessiRNAtendinopathy

Substanzen

PolymersRNA, Small InterferingBudesonideLipids

Autor:innen und Institutionen

  • Drug Research Program, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Helsinki FI-00014, Finland.
  • Centre for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria.
  • Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki FI-00014, Finland.
  • Wihuri Research Institute, Helsinki FI-00014, Finland.
  • Helsinki One Health, University of Helsinki, Helsinki FI-00014, Finland.
  • Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki FI-00014, Finland.

ORCID-Profile: Sandra López-Cerdá, Rubén Pareja Tello, Sarojinidevi Künig, Peter Steinberger, Jouni T Hirvonen, Hélder A Santos

Förderung

  • Academy of Finland
  • Universitair Medisch Centrum Groningen
  • European Commission

Zitieren

APA

López-Cerdá, S., Molinaro, G., Tello, R. P., Correia, A., Künig, S., Steinberger, P., Jeltsch, M., Hirvonen, J. T., Barreto, G., Stöckl, J., & Santos, H. A. (2024). Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c02363

Vancouver

López-Cerdá S, Molinaro G, Tello RP, Correia A, Künig S, Steinberger P, et al. Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c02363

BibTeX
@article{LpezCerd2024,
  author = {López-Cerdá, Sandra and Molinaro, Giuseppina and Tello, Rubén Pareja and Correia, Alexandra and Künig, Sarojinidevi and Steinberger, Peter and Jeltsch, Michael and Hirvonen, Jouni T and Barreto, Goncalo and Stöckl, Johannes and Santos, Hélder A},
  title = {Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c02363}
}
Kostenlos starten →